Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Monitor Dendreon

A Seeking Alpha article said to keep an eye on Dendreon Corp. (Nasdaq: DNDN) as European regulators prepare for a final decision on the company’s prostate cancer treatment Provenge. The biotechnology firm will also report second quarter earnings later this week. The stock price gained 60 cents to $5.20.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.